INDV

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to treating substance use disorders and serious mental illnesses. The company's portfolio includes medications for opioid dependence, including buprenorphine-based products marketed under various brand names. Indivior focuses on developing long-acting injectable formulations and abuse-deterrent technologies to improve treatment adherence and patient outcomes. The company combines pharmaceutical development with patient support programs to address the complex challenges of addiction treatment and recovery.